Download Files:
Products Details
Product Description
– Cdc7-IN-17 is a potent CDC7 inhibitor with an IC50 of <10 μM, extracted from patent WO2018217439A1. Cdc7-IN-17 can be used for cancer research[1].
Web ID
– HY-143431
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C13H15N5OS
References
– [1]Hai-Jun Zhang, et al. Substituted [5,6]cyclic-4(3h)-pyrimidinones as anticancer agents. Patent WO2018217439A1.
CAS Number
– 2253686-94-9
Molecular Weight
– 289.36
SMILES
– O=C1C2=C(C=C(C3=NNC=C3)S2)N=C([C@@H](N)C(C)C)N1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– CDK
Pathway
– Cell Cycle/DNA Damage
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
